Form D · Private Equity Fund

PharmaMax Co-Investment Fund, LP

Stamford, CT · CIK 0001618634

Offering snapshot reported Apr 15, 2015 · SEC filing

Reported sold
$9.15M
Offering amount: $9.15M
Investors reported
25
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
May 13, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.58M$9.15MSep 8, 2014: $2,725,000.00Sep 8, 2014Apr 15, 2015: $9,150,000.00Apr 15, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,725,000 → $9,150,000
  • Reported investors11 → 25

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 15, 2015Amendment$9,150,000$6,425,000vs Sep 8, 201425SEC filing
Sep 8, 2014Initial$2,725,000No comparison11SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-224252

Source: Form D, filed Apr 15, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph T. Draper Executive
Pharma Max Co Investment Gp, Lp Promoter
Pacific Advantage Group Ltd. Executive
Don Odell Executive
James W. White, Jr. Executive
John David Zezza Executive
David John Zezza Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
1266 East Main Street Suite 700 R
Stamford, CT, 06902